Robert De Vries and Ceo - Free people check

(1 - 10 from 11

)

SMi’s 5th Annual 3D Cell Culture Conference

www.rsc.org

Robert Vries, CEO, Hubrecht organoid Technology; Sakshi Garg, Lab Head, Discovery & Development Technologies, Merck Group; Rhiannon David, Scientific ...

LinkedIn: Robert Vries - Managing Director - Hubrecht Organoid Technology ...

Bekijk het profiel van Robert Vries op LinkedIn, de grootste professionele community ter wereld. Robert Vries heeft 10 banen functies op zijn of haar profiel. Bekijk het volledige profiel op LinkedIn om de connecties van Robert Vries en vacatures bij vergelijkbare bedrijven te zien.

Interview Released with Robert Vries, CEO at PharmiWeb.comwww.pharmiweb.com › press-release › interview-released-with-robert-vries...

www.pharmiweb.com

Nov 27, · Robert Vries received his PhD in Biochemistry from the Leiden University Medical Center on a molecular study of oncogenic transformation.

Robert de Vries | The OECD Forum Networkwww.oecd-forum.org › users › robert-de-vries

www.oecd-forum.org

Robert de Vries. CEO, Ex Nihilo BV. Follow. Ex Nihilo BV; Netherlands. Profile · Followers 0 · Community Policy · Cookie Policy · Terms & Conditions · Contact ...

Interview Released with Robert Vries, CEO at Hubrecht ...

www.pr.com

Robert Vries received his PhD in Biochemistry from the Leiden University Medical Center on a molecular study of oncogenic transformation. He subsequently moved to Stanford University (USA) to do ...

SELECTBIO - 3D-Culture, Organoids & Tox Screening Europe Speaker...

selectbiosciences.com

Robert Vries, CEO, Hubrecht Organoid Technology (HUB) Robert received his PhD in Biochemistry form the Leiden University Medical Center on a molecular study of oncogenic transformation. He subsequently moved to Stanford University (USA) to do his Post Doc studying neural stem cells.

On the Latest in Organoid Technology—Robert Vries, PhD

www.findinggeniuspodcast.com

Dec 20, · In 2009, the first-ever paper on this technology was published, and on today’s episode, CEO of Hubrecht Organoid Technology (HUB) in the Netherlands, Robert Vries, PhD dives into the details and complexity of how it’s grown since then.

SLAS Point-to-Point

multibriefs.com

SLAS The deadline to submit a podium abstract for this year's SLAS Advanced 3D Human Models and High Content Analysis Symposium (October , London, UK) ends Monday, June 17.This year's program is loaded with relevant content and expert speakers such as Robert Vries, Ph.D. and CEO of Hubrecht Organoid Technology who will be joining us as our opening keynote speaker.